Join the U.S. Progress Point Subscribers' Circle
First looks, exclusive content, and more.
-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Life Sciences
-
Healthcare
Life Sciences
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreLife Sciences
Healthcare
Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreHealthcare
U.S. PROGRESS POINT
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREBLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTS
PODCASTS
"Discover the future through our enlightening podcasts available in the United States.
EXPLORE PODCASTSInsight Brief
Launch Excellence, U.S. Edition: The Rewrite of the Business of Launch
The very lifeblood of pharma is undergoing a success transformation, commanding new metrics to reach new heights
Mar 05, 2024
Today, a successful launch is no longer defined by just dollars — it's defined by the number of patients reached, acquired, and retained. To reflect this new reality, we've refined our take on the modern launch, and carefully considered what needs to change to achieve commercial success in a pressurized environment.
New data, metrics, and understanding of patient behavior and what drives patient acquisition indicate we need to think about launch differently to maximize value – and treat as many patients as possible. In this paper, IQVIA experts discuss the clear need for a rewrite of the modern launch playbook.
New feature: Scroll down to access the audio version of this insight brief!
Audio Reading – Launch Excellence, U.S. Edition: The Rewrite of the Business of Launch
Related solutions
How Will We Remember This Moment? An Alzheimer's Perspective
The second disease-modifying Alzheimer's treatment is here with more on the horizon, but is the healthcare ecosystem ready for their impact?
Mounjaro: A New Era of Preventive Care and Consumer Health
An analysis of Mounjaro's stand-out market performance and the shifts it signals in U.S. healthcare
See The Whole Board
The Inflation Reduction Act of 2022, and the complex chess game now in play for pharmaceutical manufacturers
A Foreword — Their Finest Hour: Medical Affairs in a Disrupted World
From the U.S. Progress Point Editorial Board